Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
6,800.00    50.00 (0.74%)
Bid:
6,800.00
Ask:
6,805.00
Spread: 5.00 (0.074%)
Market Cap: £9.12b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Q3 Trading Update

17 Jul 2025 07:00

RNS Number : 3603R
Diploma PLC
17 July 2025
 

10-11 CHARTERHOUSE SQUARE, LONDON EC1M 6EE

TELEPHONE: +44 (0)20 7549 5700

 

17 July 2025

 

STRONG Q3. FURTHER FY UPGRADE.

TWO ACQUISITIONS.

 

 

Diploma PLC issues a trading update for the nine months ended 30 June 2025.

 

· Strong Q3 performance. Full year upgrade to organic growth of 10% (from 8%).

Organic growth YTD of 10%: continuation of positive trends from H1.

Reported growth YTD of 12%: +4% from acquisitions, partly offset by FX.

Strong operating margin: in line with expectations (FY guidance c.22%).

 

· Invested c.£39m in two quality acquisitions:

Haagensen A/S (Seals), adding to M-Seals' capability in Denmark.

Alpha Laboratories (Life Sciences), marks our entry into the UK In Vitro Diagnostics market.

 

 

 

---------------------------------------------------------------------------------------------------

Johnny Thomson, Chief Executive Officer, and Chris Davies, Chief Financial Officer, will host a conference call for analysts and investors this morning at 8:00am (UK time).

 

Conference call dial in details:

• Dial in: +44 (0) 33 0551 0200

• Password: Diploma Q3

 

The next scheduled update is our full year results on 18 November 2025.

 

 

 

For further information please contact:

Diploma PLC -

+44 (0)20 7549 5700

Johnny Thomson, Chief Executive Officer

 

Chris Davies, Chief Financial Officer

Holly Gillis, Head of Investor Relations

Teneo -

+44 (0)20 7353 4200

Martin Robinson

Camilla Cunningham

 

 

 

 

 

 

 

NOTE TO EDITORS:

 

Diploma's businesses deliver practical and innovative solutions that keep key industries moving. They have the technical expertise, specialist knowledge, and long-term relationships required to deliver value-add products and services that make our customers' lives easier and their outcomes better. These value-add solutions drive customer loyalty, market share growth and strong margins.

 

Our decentralised model means our specialist businesses are agile and empowered to deliver the right solutions for their customers, in their own way. As part of Diploma, our businesses can also leverage the additional resources, opportunities and expertise of a large, international and diversified Group to benefit their customers, colleagues, suppliers and communities.

 

We employ c.3,300 colleagues across our three Sectors of Controls, Seals and Life Sciences. Our principal operating businesses are located in North America, the UK, Europe, and Australia.

 

Diploma aims to deliver sustainable quality compounding, and over the last fifteen years, the Group has grown adjusted earnings per share (EPS) at an average of c.16% p.a. through a combination of organic growth and acquisitions.

Diploma is a member of the FTSE 100.

 

Further information on Diploma PLC can be found at www.diplomaplc.com

 

The person responsible for releasing this Announcement is Anna Lawrence, Group Company Secretary.

LEI: 2138008OGI7VYG8FGR19

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUBPMUPAGAQ
Date   Source Headline
23rd Jan 20184:00 pmRNSDirector Declaration
17th Jan 20184:30 pmRNSResult of AGM
17th Jan 20187:00 amRNSTrading Statement
28th Dec 20174:13 pmRNSDirector/PDMR Shareholding
12th Dec 20173:18 pmRNSHolding(s) in Company
8th Dec 20173:00 pmRNSAnnual Financial Report & Notice of AGM
27th Nov 20174:00 pmRNSDirector/PDMR Shareholding
20th Nov 20177:00 amRNSFinal Results
25th Oct 201710:00 amRNSHolding(s) in Company
25th Oct 20179:50 amRNSHolding(s) in Company
29th Sep 20174:00 pmRNSDirector Declaration
27th Sep 20177:00 amRNSDirectorate Change
26th Sep 201712:41 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSResult of Statutory Audit Tender
30th Aug 20177:00 amRNSTrading Update
17th Aug 20173:29 pmRNSHolding(s) in Company
16th Jun 20179:00 amRNSHolding(s) in Company
14th Jun 20174:05 pmRNSDirector/PDMR Shareholding
15th May 20177:00 amRNSHalf-year Report
20th Apr 20177:00 amRNSAcquisition
18th Apr 20179:44 amRNSHolding(s) in Company
30th Mar 20177:00 amRNSTrading Update
23rd Mar 20173:05 pmRNSDirector/PDMR Shareholding
13th Mar 20172:08 pmRNSHolding(s) in Company
16th Feb 20175:10 pmRNSHolding(s) in Company
14th Feb 201711:57 amRNSHolding(s) in Company
1st Feb 20177:00 amRNSCapital Markets Day
18th Jan 20174:34 pmRNSResult of AGM
18th Jan 20177:00 amRNSTrading Statement
9th Jan 201711:30 amRNSHolding(s) in Company
5th Jan 201711:26 amRNSHolding(s) in Company
22nd Dec 20164:00 pmRNSDirector/PDMR Shareholding
22nd Dec 20163:35 pmRNSDirector Declaration
8th Dec 20163:00 pmRNSAnnual Financial Report & Notice of AGM
30th Nov 20164:00 pmRNSDirector/PDMR Shareholding
21st Nov 20167:00 amRNSFinal Results
19th Oct 20162:57 pmRNSHolding(s) in Company
31st Aug 20167:00 amRNSTrading Statement
15th Aug 20164:00 pmRNSHolding(s) in Company
13th Jun 20164:00 pmRNSNotice of Adoption of FRS 101
16th May 20167:00 amRNSHalf Year Announcement
8th Apr 201611:01 amRNSHolding(s) in Company
24th Mar 20167:00 amRNSTrading Update
9th Mar 20167:00 amRNSAcquisition
17th Feb 201610:08 amRNSHolding(s) in Company
21st Jan 20161:46 pmRNSDirector/PDMR Shareholding
21st Jan 20167:00 amRNSDirectorate Change
20th Jan 20164:58 pmRNSResult of AGM
20th Jan 20167:00 amRNSFirst Quarter Trading Update
17th Dec 201510:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.